申请人:Roche Palo Alto LLC
公开号:US20150080408A1
公开(公告)日:2015-03-19
Compounds of the formula I:
or a pharmaceutically acceptable salt thereof, wherein, R
1
is optionally substituted phenyl or optionally substituted pyridinyl, and R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
and R
9
are as defined herein. Also disclosed are methods of using the compounds for treating diseases associated with P2X
3
and/or a P2X
2/3
receptor antagonists and methods of making the compounds.
化合物I的公式为:或其药学上可接受的盐,其中,R1是可选择的取代苯基或可选择的取代吡啶基,而R2、R3、R4、R5、R6、R7、R8和R9如本文所定义。还揭示了使用该化合物治疗与P2X3和/或P2X2/3受体拮抗剂相关的疾病的方法以及制备该化合物的方法。